$2.87▴ 2.50%
End-of-day close · 2026-09-01
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
Not enough data yet
Valuation
Not enough data yet
Not enough valuation history to place this in context.
Revenue growth
Not enough data yet
Not enough revenue history to measure growth.
Leverage
Not enough data yet
More coming: dilution / share-count creep.
✦ The read
Anavex Life Sciences Corp.'s earnings-quality signal is not available yet.
Key numbers
Recent news
Sentiment · last 30 days11 articles
0 bullish0 neutral11 bearish
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Anavex Life Sciences Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – AVXL
AVXL INVESTORS: Contact Kirby McInerney LLP About the Securities Fraud Lawsuit Filed on Behalf of Anavex Life Sciences Corp. Shareholders
Lead Plaintiff Deadlines in Shareholder Class Action Lawsuits Against Tigo Energy, Inc. (TYGO), Fluence Energy, Inc. (FLNC), and Anavex Life Sciences Corp. (AVXL) Announced by Holzer & Holzer, LLC